Cubist Systematic Strategies’s Ibere Pharmaceuticals IBER Stock Holding History

Cubist Systematic Strategies’s Portfolio IBER Stock Details IBER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-74,547	Closed	-$752K	–	4769
2022 Q4	$752K	Buy	74,547 +4,077	+6%	+$40.8K	﹤0.01%	2697
2022 Q3	$698K	Buy	+70,470	New	+$695K	﹤0.01%	2907
2022 Q2	–	Sell	-20,870	Closed	-$205K	–	4708
2022 Q1	$205K	Sell	20,870 -10,339	-33%	-$101K	﹤0.01%	3032
2021 Q4	$303K	Buy	+31,209	New	+$303K	﹤0.01%	2793

Cubist Systematic Strategies's IBER Position: Q1 2023 in Review

Cubist Systematic Strategies sold out of Ibere Pharmaceuticals (IBER) in Q1 2023, closing a stake of 74,547 shares — an estimated $752K sold.

Cubist Systematic Strategies first reported a position in IBER in Q4 2021 and held it in 4 quarters. The position peaked at $752K in Q4 2022. 0 funds tracked by Wall St. Rank hold IBER as of Q1 2023.

Cubist Systematic Strategies reported no remaining Ibere Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
Cubist Systematic Strategies sold 74,547 Ibere Pharmaceuticals shares in Q1 2023, an estimated $752K.
Cubist Systematic Strategies first reported a position in Ibere Pharmaceuticals in Q4 2021 and held it in 4 quarters.
Cubist Systematic Strategies's Ibere Pharmaceuticals position peaked at $752K in Q4 2022.
0 funds tracked by Wall St. Rank held Ibere Pharmaceuticals as of Q1 2023.

Based on Cubist Systematic Strategies's 13F filing for Q1 2023, filed 15 May 2023.